Back to search

Article

Monitoring and characterizing soluble and membrane-bound ectonucleotidases CD73 and CD39

2019-07-10

Abstract excerpt

The success of immunotherapy treatment in oncology ushered a new modality for treating a wide variety of cancers. However, lack of effect in some patients made it imperative to identify other pathways that are exploited by cancer cells to circumvent immune surveillance, and possibly synergize immune checkpoint treatment in those cases. It has been recently recognized that adenosine levels increased significantly i...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f035f1a5-dd45-5ca8-9c44-518e827cd7a3
DOI
10.1101/698373
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Monitoring and characterizing soluble and membrane-bound ectonucleotidases CD73 and CD39DOI 10.1101/698373
Select a neighboring publication to make it the new centre.